# Hydrops: Diagnosing & Redefining Outcomes With Precision Study

> **NCT03412760** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 500 (estimated)

## Conditions studied

- Hydrops Fetalis
- Birth Defect
- Fetal Anomaly

## Interventions

- **DIAGNOSTIC_TEST:** Exome sequencing

## Key facts

- **NCT ID:** NCT03412760
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-10-11
- **Primary completion:** 2026-12
- **Final completion:** 2027-02
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-04-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03412760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03412760, "Hydrops: Diagnosing & Redefining Outcomes With Precision Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03412760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*